If you would like to know what a PAF project is about, take a look at the testimonials of recent candidates. They are classified by region where their assignment took place. Enjoy and be inspired!Be informed
Amélie’s role consisted in leading and providing support for several digital transformation projects, mainly in the field of epilepsy, which is a priority in UCB’s pharmaceutical research.
As part of the US Digital Transformation team, Amélie contributed by researching the latest developments in digital seizure tracking solutions for patients with epilepsy. She evaluated the commercial potential of these novel devices, that allow patients to manage their epilepsy more easily. At the same time, she also reviewed UCB legacy processes and practices to assess whether they are appropriate in the frame of new digital initiatives.
Helping the company make progress on specific digital solutions for epilepsy was an enriching and fulfilling experience in a global organization like UCB. Amélie thus learned how to adapt to the company’s corporate structure.
“I have grown, in the sense that I am more aware of the connection of each aspect of the organization with a bigger whole”, she says. Overall, her resilience increased with leaps and bounds during this Prince Albert Fund year because nothing went as planned – neither her project, nor her stay abroad.
The company – UCB
UCB is a global biopharma company, focusing on neurology and immunology. It was created in 1928 in Belgium and now employs more than 7,600 people in all corners of the globe. Today it helps thousands of patients in more than 80 countries.
“Amélie really helped us progress on a portfolio framework for digital projects. In her work with the US, she was one of the first people from HQ able to bring together visibility on enablers and blockers when developing a digital solution at local level.”